Key facts
- It has raised $32.5M; the latest was Seed Round ($28.5M) in Nov 2025.
- Notable investors include Trinity Capital Inc BDC, Redesign Health.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Thrivory
- ·The full record, as it builds
Funding rounds
No funding rounds for Thrivory are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thrivory
Developer of an artificial intelligence-powered claims-based medical receivables platform designed to provide healthcare practices with rapid access to working capital. The company's platform automates claims processing, manages funding, and integrates with practice management systems, enabling healthcare providers to quickly access funds and maintain financial stability without incurring debt.
- Sector
- Healthcare
- HQ
- Oradell, NJ, United States
- Founded
- 2023
- Employees
- 10
- Website
- thrivory.com/
- Ownership
- Privately Held (backing)
Thrivory doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thrivory shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thrivory in its N-PORT filings yet. We sweep new filings monthly.